HUTCHMED (China) (HCM) Liabilities and Shareholders Equity (2016 - 2025)
HUTCHMED (China) has reported Liabilities and Shareholders Equity over the past 11 years, most recently at $1.8 billion for Q4 2025.
- Quarterly Liabilities and Shareholders Equity rose 37.58% to $1.8 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.3 billion through Dec 2025, up 7.68% year-over-year, with the annual reading at $1.8 billion for FY2025, 37.58% up from the prior year.
- Liabilities and Shareholders Equity was $1.8 billion for Q4 2025 at HUTCHMED (China), up from $1.3 billion in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $1.8 billion in Q4 2025 and troughed at $1.0 billion in Q4 2022.
- The 5-year median for Liabilities and Shareholders Equity is $1.3 billion (2023), against an average of $1.3 billion.
- Year-over-year, Liabilities and Shareholders Equity skyrocketed 89.56% in 2021 and then fell 25.0% in 2022.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $1.4 billion in 2021, then fell by 25.0% to $1.0 billion in 2022, then grew by 24.32% to $1.3 billion in 2023, then dropped by 0.44% to $1.3 billion in 2024, then soared by 37.58% to $1.8 billion in 2025.
- Per Business Quant, the three most recent readings for HCM's Liabilities and Shareholders Equity are $1.8 billion (Q4 2025), $1.3 billion (Q4 2024), and $1.3 billion (Q4 2023).